Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2720)
All Articles published online
|
Dec 21, 2007 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li LH, Guo ZJ, Yan LL, Yang JC, Xie YF, Sheng WH, Huang ZH, Wang XH. Antitumor and antiangiogenic activities of anti-vascular endothelial growth factor hairpin ribozyme in human hepatocellular carcinoma cell cultures and xenografts. World J Gastroenterol 2007; 13(47): 6425-6432 [PMID: 18081234 DOI: 10.3748/wjg.v13.i47.6425] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i47/6425.htm |
| Number | Citing Articles |
| 1 |
Jae Geun Lee, Seon Young Bak, Ji Hae Nahm, Sang Woo Lee, Seon Ok Min, Kyung Sik Kim. Toward angiogenesis of implanted bio-artificial liver using scaffolds with type I collagen and adipose tissue-derived stem cells. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2015; 19(2): 47 doi: 10.14701/kjhbps.2015.19.2.47
|
| 2 |
Mengxin Wang, Fengying Shan, Yang Zou, Xun Sun, Zhi-Rong Zhang, Yao Fu, Tao Gong. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. Journal of Controlled Release 2016; 230: 45 doi: 10.1016/j.jconrel.2016.03.036
|
| 3 |
Kurt Sartorius, Samuel O. Antwi, Anil Chuturgoon, Lewis R. Roberts, Anna Kramvis. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.891812
|
| 4 |
M Slevin, P Kumar, Quiyu Wang, S Kumar, J Gaffney, M Grau-Olivares, J Krupinski. New VEGF antagonists as possible therapeutic agents in vascular disease. Expert Opinion on Investigational Drugs 2008; 17(9): 1301 doi: 10.1517/13543784.17.9.1301
|